Magnesium for treatment of acute lacunar stroke syndromes: Further analysis of the IMAGES trial

Stroke

Volumn 38, Issue 4, 2007, Pages 1269-1273

  Aslanyan, Stella ^a   Weir, Christopher J ^a   Muir, Keith W ^a   Lees, Kennedy R ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Clinical trials; Lacunar syndrome; Magnesium

Indexed keywords

MAGNESIUM SULFATE; PLACEBO; MAGNESIUM; NEUROPROTECTIVE AGENT;

AGE; AGED; ARTICLE; BARTHEL INDEX; BLOOD PRESSURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LACUNAR STROKE SYNDROME; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; POST HOC ANALYSIS; PRIORITY JOURNAL; RANKIN SCALE; STATISTICAL MODEL; STROKE; TREATMENT OUTCOME; ACUTE DISEASE; BRAIN INFARCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HOSPITALIZATION; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; RISK FACTOR; SEX DIFFERENCE;

ACUTE DISEASE; AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; BRAIN INFARCTION; FEMALE; HUMANS; LOGISTIC MODELS; MAGNESIUM; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TREATMENT OUTCOME;

EID: 34247884551     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000259628.94421.09     Document Type: Article

References (12)

1. Intravenous Magnesium Efficacy in Stroke (IMAGES) Study Investigators. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial. Lancet. 2004;363:439-445.
2. Ransom BR, Stys PK, Waxman SG. The pathophysiology of anoxic injury in central nervous system white matter. Stroke. 1990;21:52-57.
3. Moroney JT, Bagiela E, Myunghee C, Sacco RL, Desmond DW. Risk factors or early recurrence after ischemic stroke: the role of stroke syndrome and subtype. Stroke. 1998;29:2118-2124.
4. Rankin J. Cerebral vascular accidents in patients over the age of 60, II: prognosis. Scott Med J. 1957;2:200-215.
5. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337:1521-1526.
6. Govan L, Weir CJ, Muir KW, Lees KR. Does the IMAGES stroke scale provide more information than a simple clinical classification? Cerebrovasc Dis. 2006;21:125.
7. Young FB, Lees KR, Weir CJ. Strengthening acute stroke trials through optimal use of disability endpoints. Stroke. 2003;34:2676-2680.
8. Muir KW, Grosset DG. Neuroprotection for acute stroke: making clinical trials work. Stroke. 1999;30:180-182.
9. Bamford MJ. Classical lacunar syndromes. In: Bogousslavsky J, Caplan L, eds. Stroke Syndromes, 2nd ed. Cambridge, UK: The Press Syndicate of the University of Cambridge; 2001:583-589.
10. Muir KW, Teasdale E, Lees KR. Agreement between clinical syndrome classification and brain imaging in the Intravenous Magnesium Efficacy in Stroke (IMAGES) Trial. Cerebrovasc Dis. 2006;21:124.
11. Toni D, Iweins F, von Kummer R, Busse O, Bogousslavsky J, Falcou A, Lesaffre E, Lenzi GL, for the ECASS I Group. Identification of lacunar infarcts before thrombolysis in the ECASS I study. Neurology. 2000;54:684-688.
12. Arboix A, Marti-Vilalta JL. New concepts in lacunar stroke etiology: the constellation of small-vessel arterial disease. Cerebrovasc Dis. 2004;17:58-62.